Tilray Brands, Inc. (TSE:TLRY - Get Free Report)'s stock price rose 16.5% on Tuesday . The company traded as high as C$1.07 and last traded at C$1.06. Approximately 1,941,640 shares were traded during trading, an increase of 21% from the average daily volume of 1,604,702 shares. The stock had previously closed at C$0.91.
Tilray Brands Stock Performance
The company has a quick ratio of 2.16, a current ratio of 2.54 and a debt-to-equity ratio of 10.76. The business has a 50 day moving average of C$0.66 and a 200 day moving average of C$0.94. The company has a market capitalization of C$618.59 million, a P/E ratio of -2.32 and a beta of 2.19.
Tilray Brands Company Profile
(
Get Free Report)
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Recommended Stories
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
